Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses

por Chen, Wenlan Alex, Zhang, Jinjin, Hall, Katie M., Martin, Carol B., Kisselev, Serguei, Dasen, Emily J., Vahanian, Nicholas N., Link, Charles J., Martin, Brian K.
Publicado 2017